Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China flag China · Delayed Price · Currency is CNY
20.03
-1.05 (-4.98%)
Aug 21, 2026, 3:00 PM CST

Vcanbio Cell & Gene Engineering Corp., Company Description

Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, engages in the preparation and storage of cell detection tests in the People’s Republic of China.

It offers cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, immune cells, adipose stem cells and dental stem cells.

The company also provides prenatal genetic testing for pregnancy, children and adults, disease inheritance, and disease susceptibility; and in vitro diagnostic raw materials such as monoclonal antibodies and polyclonal antibody products, and the research, development, production and sales of Class I, Class II and Class III in vitro diagnostic reagents and medical devices.

In addition, it is involved in the research, development, production, and sales of biological genes, proteins, antibodies, and pharmaceutical intermediates.

The company was founded in 1992 and is based in Tianjin, the People’s Republic of China.

Vcanbio Cell & Gene Engineering Corp., Ltd
CountryChina
Founded1992
IndustryBiotechnology
SectorHealthcare
Employees1,935
CEOHongqi Wang

Contact Details

Address:
Huayuan Industrial Zone
Tianjin, 300384
China
Phone86 22 5877 5766
Websitevcanbio.com

Stock Details

Ticker Symbol600645
ExchangeShanghai Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE000000545
SIC Code2836

Key Executives

NamePosition
Hongqi WangVice Chairman, GM and Acting Chief Financial Officer
Yu ZhangCo- President and Director
Hong Xiang ShiDeputy General Manager
Lu LiAccounting Supervisor
Dr. Huang JiaxueChief Technical Quality Officer
Yueming WangChief Human Resources Officer